Daily BriefsUnited States

Daily Brief United States: ZKH Group, ACCO Brands, Quest Diagnostics, Evolution Petroleum, Rover Group, Snap On Inc, Soluna Holdings, Zimmer Biomet Holdings and more

In today’s briefing:

  • ZKH Group IPO: The Bear Case
  • ACCO Brands Is At A Cyclical Discount
  • Quest Diagnostics Incorporated: Detailed Credit Analysis & Financial Strength Evaluation Report
  • Committed to Shareholder Returns
  • Quest Diagnostics Incorporated: Initiation of Coverage – Business Strategy & Key Drivers
  • Small Cap Idea: Rover (ROVR)
  • Snap-on Incorporated: Initiation of Coverage – Business Strategy & Recent Developments
  • Continued Evolution at Soluna as John Belizaire Appointed CEO; Dorothy Energization Imminent
  • Zimmer Biomet Holdings Inc.: Detailed Credit Analysis & Financial Strength Evaluation Report
  • Zimmer Biomet Holdings Inc.: Initiation of Coverage – Acquisition Of Embody & Other Drivers

ZKH Group IPO: The Bear Case

By Arun George

  • ZKH Group (ZKH US), a leading MRO (maintenance, repair, and operations) procurement service platform in China, is pre-marketing an NYSE IPO to raise US$200-300 million.
  • In ZKH Group IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The key elements of the bear case rest on market share losses, slowing top-line growth, declining take rates and persistent cash burn.

ACCO Brands Is At A Cyclical Discount

By Pearl Gray Equity and Research

  • ACCO Brands Corporation’s stock is relatively undervalued and presents a lucrative dividend yield worth more than 6%.
  • The company’s recent woes were a consequence of elevated raw material costs.
  • However, key metrics imply that ACCO’s cost base is set to improve.

Quest Diagnostics Incorporated: Detailed Credit Analysis & Financial Strength Evaluation Report

By Baptista Research

  • Quest Diagnostics Incorporated is a well-known provider of diagnostic information services.
  • The company produced significant double-digit growth in prenatal genetics and pharmaceutical services for sophisticated diagnostics.
  • Baptista Research looks to evaluate the different credit strengths and credit risks of the company as well as a line-by-line analysis of the financial statements of the company for the past four years.

Committed to Shareholder Returns

By Water Tower Research

  • Evolution is committed to a strategy of maximizing total shareholder returns through a combination of acquisitions to scale the business and returning cash to shareholders through dividends and common stock repurchases.
  • The strategy is underpinned by a conservative financial posture.
  • The board declared a quarterly dividend of $0.12/share for 3QFY23, marking the 38th consecutive quarterly cash dividend.

Quest Diagnostics Incorporated: Initiation of Coverage – Business Strategy & Key Drivers

By Baptista Research

  • This is our first report on leading diagnostic service provider, Quest Diagnostics Incorporated.
  • The company produced significant double-digit growth in prenatal genetics and pharmaceutical services for sophisticated diagnostics.
  • Agilent Technologies further signed an agreement with Quest to make the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test available to providers and patients across the U.S.

Small Cap Idea: Rover (ROVR)

By Value Punks

  • Rover is the world’s largest network of pet sitters and dog walkers.
  • Rover connects pet parents with pet care providers who offer overnight services, including boarding and in-home pet sitting, as well as daytime services, including doggy daycare, dog walking, and drop-in visits.
  • The marketplace has more than 500,000 pet care providers across North America and Europe.

Snap-on Incorporated: Initiation of Coverage – Business Strategy & Recent Developments

By Baptista Research

  • This is our first report on Snap-on Incorporated, a well-known manufacturer and marketer of tools, equipment, diagnostics, repair information and systems solutions in the U.S.
  • The company’s last result was an all-around beat and its organic sales growth was in the double-digits with a particularly strong performance in the Repair Systems & Information Group, high single-digit gains in the Snap-on Tools Group, and low single-digit gains in the Commercial and Industrial Group.
  • Snap-on Tools Group sales were $542.7 million, up from $504.8 million a year ago, with a 9.6% increase in organic sales.

Continued Evolution at Soluna as John Belizaire Appointed CEO; Dorothy Energization Imminent

By Water Tower Research

  • Soluna announced the promotion of John Belizaire to CEO of Soluna Holdings, with Michael Toporek stepping up to become Executive Chairman.
  • John Belizaire will remain as CEO of Soluna Computing, the operating company he founded prior to its acquisition by Soluna Holdings’ predecessor Mechanical Technology Inc. (MTI).
  • We view this as a logical step given the energization of Project Dorothy will be transformative for the company.

Zimmer Biomet Holdings Inc.: Detailed Credit Analysis & Financial Strength Evaluation Report

By Baptista Research

  • Zimmer Biomet Holdings is a global medical technology giant.
  • The management has been seeing positive comps across 2022 and saw good growth in major joints, with their entire global hip and knee business expanding well.
  • Baptista Research looks to evaluate the different credit strengths and credit risks of the company as well as a line-by-line analysis of the financial statements of the company for the past four years.

Zimmer Biomet Holdings Inc.: Initiation of Coverage – Acquisition Of Embody & Other Drivers

By Baptista Research

  • This is our first report on the global medical technology behemoth Zimmer Biomet Holdings.
  • They observed another quarter of year-over-year growth in major joints, with their entire global hip and knee business expanding by more than 8% and 10% on an ex FX basis.
  • We initiate coverage on the stock of Zimmer Biomet Holdings, Inc. with a ‘Hold’ rating.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars